NYSEARCA:PJP Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free PJP Stock Alerts $76.40 +0.75 (+0.99%) (As of 04:28 PM ET) Add Compare Share Share Today's Range$75.68▼$76.6150-Day Range$75.33▼$80.2852-Week Range$67.75▼$80.65Volume5,090 shsAverage Volume25,353 shsMarket Capitalization$268.16 millionAssets Under Management$260.38 millionDividend Yield0.98%Net Expense Ratio0.57% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get Invesco Pharmaceuticals ETF alerts: Email Address About Invesco Pharmaceuticals ETFPowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund’s investment advisor is Invesco PowerShares Capital Management LLC.Read More PJP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PJP ETF News HeadlinesApril 9, 2024 | msn.comInvesco March AUM gains 2% M/M, driven by market strengthMarch 6, 2024 | seekingalpha.comPJP Invesco Pharmaceuticals ETFApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 28, 2024 | seekingalpha.comPJP: Pharma Investing Is Difficult And This Fund Doesn't Make It EasierFebruary 24, 2024 | benzinga.comInvesco Pharmaceuticals ETF (ARCA:PJP), Quotes and News SummaryFebruary 12, 2024 | benzinga.comInvesco Exchange-Traded Fund Trust II Invesco S&P 500 High Dividend Growers ETF (ARCA:DIVG) Dividends: History, Yield and DatesSeptember 25, 2023 | finance.yahoo.comShould You Invest in the Invesco Pharmaceuticals ETF (PJP)?September 23, 2023 | investing.comInvesco Dynamic Pharmaceuticals ETF (PJP)April 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 19, 2023 | msn.comInvesco Dynamic Pharmaceuticals ETF declares quarterly distribution of $0.2013See More Headlines Receive PJP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PJP Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Pharmaceutical Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings25 Fund Statistics Assets Under Management$260.38 million Average Daily Volume$18,689.90 Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Options OptionableN/A Short Interest5,400 shs Miscellaneous Outstanding Shares3,510,000Beta0.64 Creation Unit10,000 Creation Fee$500.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. Invesco Pharmaceuticals ETF ExpensesTypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.56%0.54%0.50%0.51%Other Expenses0.07%0.40%0.54%0.64%0.58%Total Expense0.57%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%Net Expense0.57%0.60%0.60%0.58%0.58% Invesco Pharmaceuticals ETF (PJP) Holdings & ExposureTop 10 PJP HoldingsGeron(NASDAQ:GERN)Holding Weight: 6.39%Eli Lilly and Company(NYSE:LLY)Holding Weight: 5.87%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.84%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 5.83%Pfizer(NYSE:PFE)Holding Weight: 5.68%AbbVie(NYSE:ABBV)Holding Weight: 5.67%Abbott Laboratories(NYSE:ABT)Holding Weight: 5.65%Johnson & Johnson(NYSE:JNJ)Holding Weight: 5.65%Amgen(NASDAQ:AMGN)Holding Weight: 5.59%ANI Pharmaceuticals(NASDAQ:ANIP)Holding Weight: 4.18%PJP Sector ExposurePJP Industry ExposureFull Holdings Details Key ExecutivesH. Bruce Bond (Age 49)Chairman of the Board of Trustee, Chief Executive Officer Bruce T. Duncan (Age 60)Chief Financial Officer, Treasurer Kevin R. Gustafson (Age 43)Chief Compliance Officer Keith A Ovitt (Age 50)Secretary Ronn R. Bagge (Age 55)Trustee Marc M Kole (Age 53)Trustee D. Mark McMillan (Age 49)Trustee Philip M. Nussbaum Mba (Age 52)Trustee Donald H. Wilson (Age 55)Trustee More ExecutivesSimilar ETFsSPDR S&P Health Care Equipment ETFNYSEARCA:XHEInvesco Biotechnology & Genome ETFNYSEARCA:PBEInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHSPDR S&P Pharmaceuticals ETFNYSEARCA:XPHDirexion Daily Healthcare Bull 3x SharesNYSEARCA:CUREInstitutional OwnershipCambridge Investment Research Advisors Inc.Sold 912 shares on 4/25/2024Ownership: 1.132%Q3 Asset ManagementBought 13,614 shares on 4/25/2024Ownership: 0.388%Dumont & Blake Investment Advisors LLCSold 164 shares on 4/17/2024Ownership: 0.558%Wealth Enhancement Advisory Services LLCBought 1,438 shares on 4/16/2024Ownership: 0.220%Global Assets Advisory LLCBought 31,824 shares on 4/12/2024Ownership: 0.907%View All Institutional Transactions PJP ETF - Frequently Asked Questions How have PJP shares performed in 2024? Invesco Pharmaceuticals ETF's stock was trading at $76.10 at the beginning of 2024. Since then, PJP stock has increased by 0.6% and is now trading at $76.54. View the best growth stocks for 2024 here. What does PJP invest in? Invesco Pharmaceuticals ETF is a equity fund issued by Invesco. PJP focuses on health care investments and follows the Dynamic Pharmaceutical Intellidex Index. The fund's investments total to approximately $260.38 million assets under management. What stocks does Invesco Pharmaceuticals ETF hold? PJP invests in 25 holdings. Some of the stocks in their portfolio include Geron (GERN), Eli Lilly and Company (LLY), Regeneron Pharmaceuticals (REGN), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Abbott Laboratories (ABT), Johnson & Johnson (JNJ), Amgen (AMGN) and ANI Pharmaceuticals (ANIP). What is the management fee for Invesco Pharmaceuticals ETF? Invesco Pharmaceuticals ETF's management fee is 0.50% and has other expenses of 0.07%. The net expense ratio for PJP is 0.57%. What other stocks do shareholders of Invesco Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Pharmaceuticals ETF investors own include iShares 20+ Year Treasury Bond ETF (TLT), Verizon Communications (VZ), iShares Russell 2000 ETF (IWM), Akcea Therapeutics (AKCA), BOX (BOX), Kraft Heinz (KHC), Morgan Stanley (MS), Netflix (NFLX) and Applied Materials (AMAT). Who are Invesco Pharmaceuticals ETF's major shareholders? Invesco Pharmaceuticals ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Cambridge Investment Research Advisors Inc. (1.13%), Global Assets Advisory LLC (0.91%), Dumont & Blake Investment Advisors LLC (0.56%), Q3 Asset Management (0.39%) and Wealth Enhancement Advisory Services LLC (0.22%). How do I buy shares of Invesco Pharmaceuticals ETF? Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:PJP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
